Rehmann Capital Advisory Group

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1633037 LANSING, MI

Position in BCRX

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$100,410

+$4,820 QoQ

Shares Held

10,041

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#252

of 318 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $3,034,859 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	8,460	$1,425,848
2	UTHR	UNITED THERAPEUTICS Corp	2,213	$1,199,069
3	HLN	Haleon plc	33,176	$309,532
4	BCRX	Biocryst Pharmaceuticals Inc This page	10,041	$100,410

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$100,410	10,041	0.0%	Shares	Sole	2026-08-20
2026-03-31	$95,590	10,041	-1.0%	Shares	Sole	2026-05-15
2025-09-30	$76,970	10,141	0.0%	Shares	Sole	2025-11-13
2025-06-30	$90,863	10,141	-11.9%	Shares	Sole	2025-07-30
2025-03-31	$86,370	11,516	0.0%	Shares	Sole	2025-04-30
2024-12-31	$86,600	11,516	-3.8%	Shares	Sole	2025-02-14
2024-09-30	$90,941	11,966	-0.3%	Shares	Sole	2024-11-18
2024-06-30	$74,153	11,999	-0.6%	Shares	Sole	2024-08-12
2024-03-31	$61,335	12,074	0.0%	Shares	Sole	2024-05-03
2023-12-31	$72,323	12,074	-0.6%	Shares	Sole	2024-02-13
2023-09-30	$85,958	12,141	0.0%	Shares	Sole	2023-11-14
2023-06-30	$85,472	12,141	0.0%	Shares	Sole	2023-08-23
2023-03-31	$101,255	12,141	0.0%	Shares	Sole	2023-05-12
2022-12-31	$139,378	12,141	0.0%	Shares	Sole	2023-02-10
2022-09-30	$152,976	12,141	0.0%	Shares	Sole	2022-11-14
2022-06-30	$128,451	12,141	0.0%	Shares	Sole	2022-08-12
2022-03-31	$197,412	12,141	0.0%	Shares	Sole	2022-06-03
2021-12-31	$168,152	12,141	—	Shares	Sole	2022-03-02
No filing history on record for this holder in this stock.